Africa Races to Make Its Own Vaccines
African nations are accelerating efforts to develop indigenous vaccines, aiming to reduce reliance on external supplies. South Africa has begun its first in‑human HIV vaccine trial and Biovac is constructing one of the continent’s first end‑to‑end vaccine facilities. The Africa CDC is coordinating a continental immunisation plan with a goal of delivering around eleven locally produced vaccines for eight diseases within five years.
- ▪South Africa launched its first in‑human HIV vaccine trial, marking a shift toward homegrown vaccine research.
- ▪Biovac is building one of Africa’s first end‑to‑end vaccine manufacturing plants, supported by global lenders.
- ▪A global coalition pledged $62 million in June to accelerate African vaccine candidates against a deadly virus.
- ▪The Africa CDC is leading the first continent‑wide immunisation strategy to coordinate vaccine development and distribution.
- ▪The target is to have approximately eleven African‑made vaccines covering eight diseases available within the next five years.
Opening excerpt (first ~120 words) tap to expand
Southern Africa Africa Africa Races to Make Its Own Vaccines By Amina Diarra · June 26, 2026 · 5 min read Daily Brief The morning intel from across Latin America. Free. Subscribe By subscribing you agree to our privacy policy. We never share your email. SOUTH AFRICA · SCIENCE Key Facts —Homegrown trial: South Africa has launched its first in-human HIV vaccine trial, a shift from test site to scientific leader. —New factories: Biovac is building one of Africa’s first end-to-end vaccine plants, backed by global lenders. —Fast money: A global coalition pledged $62 million in June to speed African vaccine candidates against a deadly virus. —A continental plan: The Africa CDC is driving the first continent-wide immunisation strategy.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Rio Times.
Discussion
0 commentsMore from The Rio Times
